TCF — Theracryf Balance Sheet
0.000.00%
Last trade - 00:00- £4.51m
- £1.02m
Annual balance sheet for Theracryf, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11.6 | 9.03 | 5 | 2 | 4.11 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.652 | 0.483 | 1.02 | 0.972 | 1.01 |
| Prepaid Expenses | |||||
| Total Current Assets | 12.3 | 9.58 | 6.13 | 3.03 | 5.17 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.005 | 0.005 | 0.003 | 0.001 | — |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 12.4 | 9.64 | 6.17 | 3.06 | 7.63 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.607 | 0.411 | 0.833 | 0.723 | 1.66 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.607 | 0.411 | 0.833 | 0.721 | 1.66 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 11.8 | 9.23 | 5.34 | 2.34 | 5.97 |
| Total Liabilities & Shareholders' Equity | 12.4 | 9.64 | 6.17 | 3.06 | 7.63 |
| Total Common Shares Outstanding |